Anti-embolism stockings, also known as compression stockings, are elastic garments that are worn on the legs to improve blood circulation and prevent blood clots. These stockings are designed to provide graduated compression, which means they are tighter at the ankles and gradually loosen towards the top of the stockings. Anti-embolism stockings are commonly used in hospitals and are recommended for individuals who are at risk of developing blood clots.
Market Segmentation:
The global anti-embolism stockings market is segmented based on product type, distribution channel, and region.
Based on product type, the market is segmented into gradient stockings and anti-embolism stockings. Anti-embolism stockings are the most commonly used type and account for the largest market share.
Based on the distribution channel, the market is segmented into hospitals, clinics, online stores, and others. Hospitals are the largest end-user of anti-embolism stockings, followed by clinics.
To remain ‘ahead’ of your competitors, request for a samples @ https://www.persistencemarketresearch.com/samples/33355
Regional Analysis:
The global anti-embolism stockings market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America is the largest market for anti-embolism stockings, followed by Europe and Asia-Pacific. The high prevalence of venous disorders, the growing geriatric population, and the increasing number of surgeries are driving the market’s growth in North America. The Asia-Pacific region is expected to witness significant growth during the forecast period due to the increasing adoption of compression therapy and the rising geriatric population.
Key Players:
Some of the key players operating in the global anti-embolism stockings market are BSN Medical GmbH, 3M Company, Medtronic plc, Sigvaris Management AG, Cardinal Health, Inc., THUASNE SA, Cizeta Medicali S.r.l., Integra LifeSciences Holdings Corporation, and Mölnlycke Health Care AB.
Conclusion:
In conclusion, the global anti-embolism stockings market is witnessing significant growth due to the increasing prevalence of venous disorders, the rising geriatric population, and the increasing adoption of compression therapy. The market is highly competitive, with several players operating in the market. The market is expected to continue its growth trajectory during the forecast period, driven by the increasing awareness about the benefits of anti-embolism stockings and the growing customization options available in the market.